Better understanding of allergies for better treatment
ALYATEC has created an environmental exposure chamber (EEC) in Strasbourg, offering to pharmaceutical companies and public institutes a research tool unique in the world.
This environmental exposure chamber, also called allergen challenge chamber, allows to perform clinical studies under standardized, reproducible and controlled conditions to validate desensitization treatments and innovative drug candidates aiming to treat symptoms of respiratory allergies related to asthma, rhinitis and conjunctivitis.
ALYATEC allergen challenge chamber also helps fundamental research on respiratory allergies by studying mechanisms and onset of action of these pathologies. Respiratory allergies is a major concern which currently affects about 25% of Europeans.
Our expertise in research and clinical trials applies to all innovative solutions fighting against respiratory allergies. It makes possible to evaluate the effect of new therapeutics as well as alternative solutions such as medical devices, air cleaners, respiratory masks, pollen filters or acaricide products. Thereby, ALYATEC allergen challenge chamber contributes to the improvement of patients’ daily life. Discover the partners who already trust us.
By Alyatec
The human vaginal mucosa is comprised of a protective multilayered epithelium with a squamous, stratified…
Veganism is no longer just a dietary choice; it’s a full lifestyle movement that influences…
The European Commission (EC) is hosting a free, one-hour webinar, “When Beauty Meets Green: The…